GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Purchase Of Business

Amicogen (XKRX:092040) Purchase Of Business : ₩-8,747 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Purchase Of Business?

Amicogen's purchase of business for the three months ended in Dec. 2023 was ₩-3,873 Mil. It means Amicogen spent ₩3,873 Mil on purchasing business. Amicogen's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-8,747 Mil.

Compared with last quarter (₩-2,467 Mil in Sep. 2023 ), Amicogen spent more money on purchasing business in Dec. 2023 (₩-3,873 Mil).

Amicogen Purchase Of Business Historical Data

The historical data trend for Amicogen's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Purchase Of Business Chart

Amicogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -745.04 -6,466.06 -8,746.55

Amicogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,667.61 -907.30 -1,499.96 -2,466.66 -3,872.63

Amicogen Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,747 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amicogen Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Amicogen's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Amicogen (XKRX:092040) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Purchase Of Business
Comparable Companies
XKRX:000020 XKRX:005500 XKRX:102460 XKRX:084110 XKRX:058820 XKRX:007570 XKRX:001630 XKRX:096760 XKRX:293480 XKRX:102940 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Website
http://www.amicogen.com
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines